Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CVS Health Corp (NY:CVS)

70.97 +0.80 (+1.14%)
Official Closing Price Updated: 7:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
Michael Burry and Warren Buffett invested in UnitedHealth, signaling confidence in its sector and potential for earnings recovery by 2027. 
Via Benzinga
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
What Does the Market Think About CVS Health?
 
Via Benzinga
Price Over Earnings Overview: CVS Health
 
Via Benzinga
Costco Refuses To Stock Abortion Pill Mifepristone, Pointing To 'Low Demand' As Activist Groups Step Up Pressure On Retail Giants
Costco won't sell abortion pill mifepristone in U.S. stores due to low demand amid pressure from religious groups. 
Via Benzinga
Topics Religion
Corporate Crossroads: Government Eyes Intel Stake as Buffett Bets on Healthcare Giant
In a striking display of market intervention and strategic investment, two major corporate developments are sending ripples through the financial world. The U.S. government is reportedly considering an... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Inflation's Conundrum: Surging Producer Prices Clash with Steady Consumer Costs, Fueling Rate Uncertainty
The financial markets are grappling with a perplexing economic puzzle as recent inflation data presents a contradictory picture. July 2025 saw the Producer Price Index (PPI) surge significantly,... 
Via MarketMinute
Topics Economy Energy Supply Chain
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Q2 Earnings Highlights: AMN Healthcare Services (NYSE:AMN) Vs The Rest Of The Healthcare Providers & Services Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services... 
Via StockStory
Synergy Corp (NASDAQ: SNYR) “FOCUSfactor” Q2 +125% YoY Growth, 10th Consecutive Profitable Quarter – More Stocks Inside
Via AB Newswire
Assessing CVS Health: Insights From 6 Financial Analysts
 
Via Benzinga
Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Cencora (NYSE:COR) and the rest... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Healthcare Providers & Services Stocks Q2 Highlights: Pediatrix Medical Group (NYSE:MD)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Pediatrix Medical Group (NYSE:MD) and its peers. 
Via StockStory
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non-GAAP profit of $1.81 per share was... 
Via StockStory
2 Large-Cap Stocks on Our Buy List and 1 We Avoid
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for... 
Via StockStory
Synergy Inc. (NASDAQ: SNYR) CEO on Air Spotlights on FOCUSfactor® Legacy, Energy Beverage & Weight Loss – Poised for Explosive Growth – More Stocks Inside
Via AB Newswire
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today
Via Stocktwits
Which S&P500 stocks are moving on Tuesday?
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
The Smartest Dividend Stocks to Buy With $500 Right Now
Dividend stocks are an ideal way to diversify your portfolio and also earn extra income. 
Via The Motley Fool
5 Dividend Stocks With Solid Returns And More Growth Ahead
 
Via Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation. 
Via Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
The firm now expects full-year adjusted earnings per share of $6.30 to $6.40, up from its previous guidance of $6.00 to $6.20. 
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Gapping S&P500 stocks in Thursday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
CVS Health Will Invest $20 Billion To Simplify US Health System, Delivers Strong Q2 Despite Legal Setbacks
CVS Health reported strong Q2 results with revenue and adjusted earnings surpassing estimates and raised its full-year 2025 guidance. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.